Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity

BACKGROUND: As a first-line diabetes drug that is widely prescribed around the world, metformin has been demonstrated to be effective in reducing microvascular risk, in addition to lowering glucose levels. Specifically, metformin use has been shown to be associated with improved lipid profiles, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Gao, Feng, Luo, Hao, Zhang, Chun-Ting, Zhang, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465464/
https://www.ncbi.nlm.nih.gov/pubmed/26068179
http://dx.doi.org/10.1186/s12933-015-0240-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465464/
https://www.ncbi.nlm.nih.gov/pubmed/26068179
http://dx.doi.org/10.1186/s12933-015-0240-1

Ejemplares similares